COPD exacerbation Flashcards
Mucolytics function
- which drugs are mucolytics
- how are they administered
- what ADR can they cause?
1) drugs that react directly with mucus to make it less VISCOUS - makes coughing more productive
2) two agents:
- acetylcysteine
- hypertonic saline
both agents are administered via inhalation and unfortunately can trigger FURTHER BRONCHOSPASM
Acetylcysteine indications
mucolytic, acetaminophen OD
Acetylcysteine MOA
lowers mucus viscosity allowing for more productive cough
acetylcysteine routes CAUTION
- nebulized inhalation
- oral tabs, IV (Acetaminophen OD)
acetylcysteine adr
bronchospasm
hypertonic saline indications
mucolytic
MOA of hypertonic saline
restores moisture to pulmonary system and allows for more productive cough
Route hypertonic saline
Nebulized inhalation preferred
ADR hypertonic saline
bronchospasm
Cough suppressants
- what does coughing involve?
- how is coughing initiated?
- what is cough beneficial for?
- when should a cough be suppressed?
- coughing is a complex reflex involving the CNS, PNS, and muscles of respiration
- can be initiated by the irritation of the bronchial mucosa or stimuli at sites distant froom the RT
- cough is often beneficial when removing foreign matter and excessive secretions- these should not be typically suppressed
- non-productive coughs that create discomfort or deprive a patient of sleep are reasonoable to suppress
Antitussive drugs
- suppress cough but do NOT treat the underlying condition
- opioid antitussives-
- codeine
- non- opioid antitussives
- benzonotate
- antihistamines ( prromethazine, diphenhydramine)
- dextromethorphan
codeine indcations
cough (off label)
pain managment
US box warnings for codeine
- ultra rapid metabolism of codeine- life threatening respiratory depression has occurred. most cases after TONSILLECTOMY and or adenoidectomy. many had evidence of being ultra rapid metabolizer d/t CYP2D6 polymorphism
- cytochrome p450 3a4 inhibitors- coadministration may cause increased hydrocodone plasma
MOA of Codeine
cough suppressant by direct central action in the medulla
- converted by CYP 2d6 into morphine
contraindications for codeine
- pediatrics <12 y/o
- post op pain management in peds <18 who have undergone tonsillectomy or adenoiodectomy
- concurrent MAOI administration or within the last 14 days
dextromethorphan indications
cough suppressant
MOA dextromethorphan
depresses the medullary cough center and interrupts cough impulse transmission (similar structure to codeine)
contraindications to dextromethorphan
concurrent administration with or w/in 2 weeks of an MAOI
ADR of dextromethorphan
- euphoria - similar to ecstasy/ alcohol intoxication and at higher doses - ketamine - intense hallucinations
- drowsiness, dizziness, restlessness
Benzonatate indications
cough suppressant